Search research articles
Contact Us
Filters
Showing results (611-620 of 764) with videos related to
Page
of 77
Sort By:
Lancet (London, England)
|
September 3, 2025
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
Marco Valgimigli, Ki Hong Choi, Daniele Giacoppo, et al.
JAMA
|
January 19, 2012
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
Dominick J Angiolillo, Michael S Firstenberg, Matthew J Price, et al.
Blood Advances
|
March 29, 2018
Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction
Oliver Borst, Patrick Münzer, Nada Alnaggar, et al.
American Heart Journal
|
December 5, 2016
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study
Usman Baber, George Dangas, David J Cohen, et al.
Annals of Internal Medicine
|
July 21, 2020
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial
Maurizio Menichelli, Franz-Josef Neumann, Gjin Ndrepepa, et al.
Cardiovascular Diabetology
|
October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JAMA Internal Medicine
|
October 12, 2020
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis
Mario Gaudino, Irbaz Hameed, Michael E Farkouh, et al.
JACC. Basic to Translational Science
|
August 22, 2024
Clopidogrel-Mediated P2Y<sub>12</sub> Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
Journal of Cardiovascular Translational Research
|
December 24, 2013
Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation
José Luis Ferreiro, José Carlos Sánchez-Salado, Montserrat Gracida, et al.
Journal of the American College of Cardiology
|
April 23, 2013
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study
Paul A Gurbel, Kevin P Bliden, Douglas K Logan, et al.
Page
of 77
Search research articles
Search
Showing results (611-620 of 764) with videos related to
Sort By:
Page
of 77
Lancet (London, England)
|
September 3, 2025
Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis
Marco Valgimigli, Ki Hong Choi, Daniele Giacoppo, et al.
JAMA
|
January 19, 2012
Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery: a randomized controlled trial
Dominick J Angiolillo, Michael S Firstenberg, Matthew J Price, et al.
Blood Advances
|
March 29, 2018
Inhibitory mechanisms of very low-dose rivaroxaban in non-ST-elevation myocardial infarction
Oliver Borst, Patrick Münzer, Nada Alnaggar, et al.
American Heart Journal
|
December 5, 2016
Ticagrelor with aspirin or alone in high-risk patients after coronary intervention: Rationale and design of the TWILIGHT study
Usman Baber, George Dangas, David J Cohen, et al.
Annals of Internal Medicine
|
July 21, 2020
Age- and Weight-Adapted Dose of Prasugrel Versus Standard Dose of Ticagrelor in Patients With Acute Coronary Syndromes : Results From a Randomized Trial
Maurizio Menichelli, Franz-Josef Neumann, Gjin Ndrepepa, et al.
Cardiovascular Diabetology
|
October 17, 2020
Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
Chao Gao, Mariusz Tomaniak, Kuniaki Takahashi, et al.
JAMA Internal Medicine
|
October 12, 2020
Overall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis
Mario Gaudino, Irbaz Hameed, Michael E Farkouh, et al.
JACC. Basic to Translational Science
|
August 22, 2024
Clopidogrel-Mediated P2Y<sub>12</sub> Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD
Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, et al.
Journal of Cardiovascular Translational Research
|
December 24, 2013
Impact of mild hypothermia on platelet responsiveness to aspirin and clopidogrel: an in vitro pharmacodynamic investigation
José Luis Ferreiro, José Carlos Sánchez-Salado, Montserrat Gracida, et al.
Journal of the American College of Cardiology
|
April 23, 2013
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study
Paul A Gurbel, Kevin P Bliden, Douglas K Logan, et al.
Page
of 77